由YAP/TEAD4诱导的PKP2促进了胃癌恶性进展
Yunyun Liu1,2, Yi Lu2, Yuanxin Xing1,2
1Research Center of Basic Medicine, Jinan Central Hospital, Shandong University, Jinan, China.
在胃癌 (GC) 中,Plakophilin-2 (PKP2) 被上调,与晚期瘤阶段和不良预后相关. 针对YAP1/TEAD4规范的PKP2,为GC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是异质的,预后不佳,需要新的诊断和治疗策略.
- 包括Plakophilin-2 (PKP2) 在内的desmosome蛋白与癌症进展有关.
- 异常PKP2表达与各种瘤类型有关.
研究的目的:
- 调查Plakophilin-2 (PKP2) 在胃癌 (GC) 中的作用.
- 探索GC中PKP2的调节机制.
- 评估PKP2作为预后生物标志物和GC的治疗标.
主要方法:
- 在GC组织中分析PKP2表达.
- 分析PKP2表达,瘤阶段和预后之间的相关性.
- 研究PKP2转录的YAP1/TEAD4调节.
- 对AKT/mTOR信号通路的评估.
- 使用鼠标模型进行验证.
主要成果:
- 发现PKP2在GC上升调节.
- 增加PKP2表达与晚期瘤阶段和不良预后相关.
- YAP1/TEAD4复合体刺激了GC中的PKP2转录.
- AKT/mTOR信号的PKP2激活促进了GC的进展.
- 在体内研究验证了PKP2在GC中的作用.
结论:
- 由YAP1/TEAD4调节的PKP2是GC恶性进展的关键驱动因素.
- PKP2 作为一种潜在的GC进展和预后指标.
- PKP2代表了胃癌的一个有前途的治疗标.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
